Reuters – Hedge fund Diamondback Capital Management, which had been embroiled in the government’s insider trading case, has agreed to pay back roughly $1 million to settle an insider trading case, according to a court filing released on Wednesday.
The Stamford, Connecticut-based firm, which has not been accused of any wrongdoing, made the money after a former portfolio manager illegally traded on a tip that Axcan Pharma would be acquired.
